Real-time enrollment status for this secondary aml clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 1:30 PM UTC
| NCT Number | NCT07250646 |
| Recruiting Status | Recruiting |
| Condition | Secondary AML |
| Phase | PHASE1 |
| Target Enrollment | 28 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Aspera Biomedicines, Inc. |
| Last Updated on CT.gov | July 20, 2026 (Jul 20, 2026) |
As of August 31, 2026: Clinical trial NCT07250646 is currently recruiting participants. This phase1 study for secondary aml is actively seeking new participants at 3 locations across the United States. The study is sponsored by Aspera Biomedicines, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07250646 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07250646 was last updated Jul 20, 2026 (July 20, 2026). HelloStudys verifies this status automatically.